Antibodies against oxidized low-density lipoprotein in normolipidemic smokers

American Journal of Cardiology

Volumn 90, Issue 6, 2002, Pages 651-653

  Zaratin, Águeda ^a   Gidlund, Magnus ^b   Boschcov, Paulo ^c   Castilho, Lúcia ^a   Cotta De Faria, Eliana ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN ANTIBODY; TRIACYLGLYCEROL;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; OXIDATION; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTIBODIES; BIOLOGICAL MARKERS; BODY CONSTITUTION; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS, LDL; MALE; REFERENCE VALUES; SMOKING; STATISTICS;

EID: 0037106963     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)02576-6     Document Type: Article

References (20)

1. Hulea S.A., Olinescu R., Nita S., Crocnan D., Kummerow F.A. Cigarette smoking causes biochemical changes in blood that are suggestive of oxidative stress a case-control study . J Environ Pathol Toxicol Oncol. 14:1995;173-180.
2. Gouazé V., Dousset N., Dousset J.C., Valdiguie P. Effect of nicotine and cotinine on the susceptibility to in vitro oxidation of LDL in healthy non smokers and smokers. Clin Chim Acta. 277:1998;25-37.
3. Siekmeier R., Wulfroth P., Wieland H., Gross W., Marz W. Low-density lipoprotein susceptibility to in vitro oxidation in healthy smokers and nonsmokers. Clin Chem. 42:1996;524-530.
4. Chen C., Loo G. Cigarette smoke extract inhibits oxidative modification of low density lipoprotein. Atherosclerosis. 112:1995;177-185.
5. Porkka K.V., Ehnholm C. Smoking, alcohol and lipoprotein metabolism. Curr Opin Lipidol. 7:1996;162-166.
6. Bachorik P.S., Albers J.J. Precipitation methods for quantification of lipoproteins. Methods Enzymol. 129:1986;78-100.
7. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
8. De Lalla O., Gofman J.W. Ultracentrifugal analysis of serum lipoproteins and proteins in man. Glick D., Methods of Biochemical Analysis. 1954;459-478 Interscience Rub Inc. New York.
9. Puhl H., Waeg G., Esterbauer H. Methods to determine oxidation of low-density lipoproteins. Methods Enzymol. 233:1994;425-441.
10. Gidlund M., Damasceno N.R., Lindoso J.A., Abdalla D.S., Goto H. Monoclonal antibodies against low density lipoprotein with various degrees of oxidative modifications. Braz J Med Biol Res. 29:1996;1625-1628.
11. Rimm E.B., Stampfer M.J., Giovannucci E., Ascherio A., Spiegelman D., Colditz G.A., Willett W.C. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol. 141:1995;1117-1127.
12. Holvoet P., Mertens A., Verhamme P., Bogaerts K., Beyens G., Verhaeghe R., Collen D., Muls E., Van de Werf F. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 21:2001;844-848.
13. Wu R., de Faire U., Lemne C., Witztum J.L., Frostegard J. Autoantibodies to OXLDL are decreased in individuals with boderline hypertension. Hypertension. 33:1999;53-59.
14. Fukumoto M., Shoji T., Emoto M., Kawagishi T., Okuno Y., Nishizawa Y. Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population. Arterioscler Thromb Vasc Biol. 20:2000;703-707.
15. Uusitupa M.I., Niskanen L., Luoma J., Vilja P., Mercuri M., Rauramaa R., Yla-Herttuala S. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 16:1996;1236-1242.
16. Damasceno N.R.T., Goto H., Rodrigues F.M.D., Dias C.T.S., Okawabata F.S., Abdalla D.S.P., Gidlund M. Soy protein isolated reduces the oxidizability of LDL and generation of oxidized LDL autoantibodies in rabbits with diet-induced atherosclerosis. J Nutr. 130:2000;2641-2647.
17. Shoenfeld Y., Harats D., George J. Heat shock protein 60/65, beta 2-glycoprotein I and oxidized LDL as players in murine atherosclerosis. J Autoimmun. 15:2000;199-202.
18. Mustafa A., Nityanand S., Berglund L., Lithell H., Lefvert A.K. Circulating immune complexes in 50-year-old men as a strong and independent risk factor for myocardial infarction. Circulation. 102:2000;2576-2581.
19. Shoji T., Nishizawa Y., Fukumoto M., Shimamura K., Kimura J., Kanda H., Emoto M., Kawagishi T., Morii H. Inverse relationship between circulating oxidized low density lipoprotein (OX-LDL) and anti-OX-LDL antibody levels in healthy subjects. Atherosclerosis. 148:2000;171-177.
20. Hulthe J., Wikstrand J., Lidell A., Wendelhag I., Hansson G.K., Wiklund O. Antibody titers against oxidized LDL are not elevated in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 18:1998;1203-1211.